Perspectives of primary health care staff on the implementation of a sexual health quality improvement program: a qualitative study in remote aboriginal communities in Australia

Autor: Belinda Hengel, Stephen Bell, Linda Garton, James Ward, Alice Rumbold, Debbie Taylor-Thomson, Bronwyn Silver, Skye McGregor, Amalie Dyda, Janet Knox, Rebecca Guy, Lisa Maher, John Martin Kaldor, on behalf of the STRIVE Investigators

Publikováno v: BMC Health Services Research, Vol 18, Iss 1, Pp 1-12 (2018)

Abstract Background Young people living in remote Australian Aboriginal communities experience high rates of sexually transmissible infections (STIs). STRIVE (STIs in Remote communities, ImproVed and Enhanced primary care) was a cluster randomised co

Externí odkaz: https://doaj.org/article/0f8dc2128c5e46218c6566cc937dc06b

Strategies to improve control of sexually transmissible infections in remote Australian Aboriginal communities: a stepped-wedge, cluster-randomised trial

Autor: Basil Donovan, Belinda Hengel, Amalie Dyda, Christopher K Fairley, Skye McGregor, Strive investigators, Debbie Taylor-Thomson, Jacqueline Mein, Linda Garton, Handan Wand, Matthew Law, Donna Ah Chee, Rebecca Guy, James Ward, Carole Reeve, Nathan Ryder, Bronwyn Silver, Lisa Maher, John Boffa, Elizabeth Moore, John M. Kaldor, Alice R. Rumbold, Janet Knox, Hamish McManus, Steven Skov

Publikováno v: The Lancet Global Health, Vol 7, Iss 11, Pp e1553-e1563 (2019)

Summary Background Remote Australian Aboriginal communities have among the highest diagnosed rates of sexually transmissible infections (STIs) in the world. We did a trial to assess whether continuous improvement strategies related to sexual health c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ede977d9ec24fb19feb6d890b8679f5
http://www.sciencedirect.com/science/article/pii/S2214109X19304115

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

Autor: Strive Investigators, Wolfgang Dummer, Simon Jones, Roberto Giugliani, Maurizio Scarpa, Vassili Valayannopoulos, Shuan-Pei Lin, Paul Harmatz, Debra L. Lounsbury, Barbara K. Burton, Peter Slasor, Thomas R. Fleming, Derralynn Hughes, Eugen Mengel, Christian J. Hendriksz

Publikováno v: STRIVE Investigators 2014, ' Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA) : A phase 3 randomised placebo-controlled study ', Journal of Inherited Metabolic Disease, vol. 37, no. 6, pp. 979-990 . https://doi.org/10.1007/s10545-014-9715-6
Journal of Inherited Metabolic Disease

Objective To assess the efficacy and safety of enzyme replacement therapy (ERT) with BMN 110 (elosulfase alfa) in patients with Morquio A syndrome (mucopolysaccharidosis IVA). Methods Patients with Morquio A aged ≥5 years (N = 176) were randomised

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce90913ba268a2a462fbbf7743596e0
https://doi.org/10.1007/s10545-014-9715-6

Patient, staffing and health centre factors associated with annual testing for sexually transmissible infections in remote primary health centres

Autor: Belinda Hengel, Handan Wand, James Ward, Alice Rumbold, Linda Garton, Debbie Taylor-Thomson, Bronwyn Silver, Skye McGregor, Amalie Dyda, Jacqueline Mein, Janet Knox, Lisa Maher, John Kaldor, Rebecca Guy, null on behalf of the STRIVE Investigators

Publikováno v: Sexual health. 14(3)

Background: In high-incidence Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) settings, annual re-testing is an important public health strategy. Using baseline laboratory data (2009–10) from a cluster randomised trial in 67 remote Aborig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb3db6a335a38893d8a5bcdf8806c14c
https://pubmed.ncbi.nlm.nih.gov/28445684

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.